Published in
Springer Nature [academic journals on nature.com], British Journal of Cancer, 4(108), p. 762-765, 2013
DOI: 10.1038/bjc.2012.604
Links
- ORCID
- ORCID
- Springer Nature [academic journals on nature.com] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies
Journal article published in 2013 by
Rd D. Harvey 
,
Tk K. Owonikoko ,
Cm M. Lewis,
A. Akintayo,
Z. Chen,
M. Tighiouart,
Ss S. Ramalingam,
M. P. Fanucchi,
P. Nadella,
D. M. Shin,
A. Rogatko,
B. El-Rayes,
F. R. Khuri,
J. S. Kauh
,
Tk K. Owonikoko ,
Cm M. Lewis,
A. Akintayo,
Z. Chen,
M. Tighiouart,
Ss S. Ramalingam,
M. P. Fanucchi,
P. Nadella,
D. M. Shin,
A. Rogatko,
B. El-Rayes,
F. R. Khuri,
J. S. Kauh
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 